Kisqali (ribociclib) - Novartis
Ibrance (palbociclib) - Pfizer
Verzenio (abemaciclib) - Eli Lilly
Truqap (capivasertib) - AstraZeneca
fulvestrant - Generic mfg.
http://clinicaltrials.gov/ct2/show/NCT04862663
 
Aug 18, 2026
 
Prev Next